2m 2m 2m 2m 2m 2m 2m
CELLDEX THERAPTC (CLDX)
NASDAQ
$31.67-$0.52 (-1.60%)
Price as of Oct 02, 2026 5:07 PM EDT- $2.5BMarket Cap
- 24.49%1-Year Change
- BiotechnologyIndustry
CELLDEX THERAPTC (CLDX)
$31.67-$0.52 (-1.60%)
CLDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $32.18 | ||
Change | -$0.23 (-0.71%) | ||
Open | $32.26 | ||
High | $32.55 | ||
Low | $31.70 | ||
Previous Close | $32.41 | ||
Volume | 1,443,329 | ||
30-Day Average Volume | 1,868,009 | ||
1-Week Change | 2.22% | ||
1-Month Change | -17.99% | ||
1-Year Change | 24.49% | ||
3-Year Change | 16.93% | ||
5-Year Change | -42.41% | ||
Fundamentals | |||
Shares Outstanding | 78.5M | ||
Total Assets | $782.3M | ||
Market Cap | $2.5B | ||
Enterprise Value | $2.5B | ||
Period: QTR TTM FY | |||
Revenue | $7,000.00 | ||
Net Income | -$73.5M | ||
Free Cash Flow | -$60.6M | ||
EBIT | -$73.5M | ||
EBITDA | -$72.6M | ||
Net Working Capital | $663.6M | ||
EPS | -$0.94 | ||
Enterprise Value/EBITDA | -34 | ||
Enterprise Value/Revenue | 354,232 | ||
P/B | 4 | ||
P/E | -34 | ||
PEG | -2 | ||
Price/Free Cash Flow | -42 | ||
Price/Operating Cash Flow | -44 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 02/11/2019 | ||
Earnings & Revenue